GENE ONLINE|News &
Opinion
Blog

2022-10-19| In-DepthSpecial

Synthetic Biology: A Rising Interdisciplinary Field that Revolutionizes the Biomedical Industry

by GeneOnline
Share To
With rapid technological advancements after 2010, synthetic biology is a rising star in biotechnology, covering a wide range of fields, including food, medicine, and biofuels. A new definition of the biology system has evolved through innovative bioengineering technologies, and some scholars regard it as a technology that revolutionizes the bioeconomy. Synthetic biology provides innovative and revolutionary solutions for global healthcare, agriculture, manufacturing, and even green energy, already achieving many remarkable results. 

According to a 2022 report by the BioMed Commercialization Center (BMCC) in Taiwan, the global market size for synthetic biology approached US$15 billion in 2021. The report conservatively estimates that it will climb beyond $65 billion by 2026 at a compound annual growth rate of 35%. An article published in Nature Communications in 2020 even boldly predicted that by 2030, our food, clothing, daily commodities, and medical products would all be made possible by synthetic biology. As a result, synthetic biology is emerging as an essential part of our lives.

It's free! Log in now to read

LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top